We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients.
- Authors
Chenevier-Gobeaux, Camille; Ducastel, Morgane; Meritet, Jean-François; Ballaa, Yassine; Chapuis, Nicolas; Pene, Frédéric; Carlier, Nicolas; Roche, Nicolas; Szwebel, Tali-Anne; Terrier, Benjamin; Borderie, Didier
- Abstract
(1) Background: Endocan is a marker of endothelial dysfunction that may be associated with thrombotic events. The aim of the study was to investigate the performance of endocan as a marker of thrombotic events in COVID-19 patients. (2) Methods: We measured endocan in plasma from 79 documented COVID-19 patients classified according to disease severity (from mild to critical). Thrombotic events were recorded. (3) Results: Endocan concentrations at admission were significantly increased according to COVID-19 severity. Levels of endocan were significantly increased in patients experiencing thrombotic events in comparison with those without (16.2 (5.5–26.7) vs. 1.81 (0.71–10.5) ng/mL, p < 0.001). However, endocan concentrations were not different between pulmonary embolism and other thrombotic events. The Receiver Operating Characteristic (ROC) analysis for the identification of thrombotic events showed an area under the ROC curve (AUC) of 0.776 with an optimal threshold at 2.83 ng/mL (93.8% sensitivity and 54.7% specificity). When combining an endocan measurement with D-dimers, the AUC increased to 0.853. When considering both biomarkers, the Kaplan–Meier survival curves showed that the combination of endocan and D-dimers better discriminated patients with thrombotic events than those without. The combination of D-dimers and endocan was independently associated with thrombotic events. (4) Conclusions: Endocan might be a useful and informative biomarker to better identify thrombotic events in COVID-19 patients.
- Subjects
COVID-19; COVID-19 pandemic; RECEIVER operating characteristic curves; BIOMARKERS; ENDOTHELIUM diseases
- Publication
Journal of Clinical Medicine, 2022, Vol 11, Issue 19, p5560
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm11195560